The Synergistic Effect Study of Lipopolysaccharide (LPS) and A53T-α-synuclein: Intranasal LPS Exposure on the A53T-α-synuclein Transgenic Mouse Model of Parkinson's Disease
Cited by 1
Related Papers
Liver X receptor agonist treatment attenuates cardiac dysfunction in type 2 diabetic db/db mice
|Cardiovascular Diabetology|2014|51